Calidi Biotherapeutics, Inc. Quarterly Earnings Per Share, Basic in USD/shares from Q3 2022 to Q2 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Calidi Biotherapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q3 2022 to Q2 2025.
  • Calidi Biotherapeutics, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2025 was -1.99 USD/shares, a 88.1% increase year-over-year.
  • Calidi Biotherapeutics, Inc. Earnings Per Share, Basic for the twelve months ending June 30, 2025 was 13 USD/shares.
  • Calidi Biotherapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -2.97 USD/shares, a 82.9% increase from 2023.
  • Calidi Biotherapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -17.3 USD/shares, a 680% decline from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $13.00 -$2 +$14.80 +88.1% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-08
Q1 2025 -$1 $0 +$1.85 +91.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 -$2 $16.50 +$17.40 Oct 1, 2024 Dec 31, 2024 10-K 2025-03-31
Q3 2024 -$20 -$1 +$0.76 +53.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$21 -$17 -$3 -17.6% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-08
Q1 2024 -$18 -$2 -$1 -171% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 -$17 -$1 Oct 1, 2023 Dec 31, 2023 10-K 2025-03-31
Q3 2023 -$1 -$1 -124% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$14 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 -$1 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.